Home Cart Sign in  
Chemical Structure| 552-41-0 Chemical Structure| 552-41-0

Structure of Paeonol
CAS No.: 552-41-0

Chemical Structure| 552-41-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Paeonol is a naturally occuring MAO inhibitor with IC50 values of 54.6 μM and 42.5 μM for MAO-A and MAO-B, respectively.

Synonyms: 2'-Hydroxy-4'-methoxyacetophenone; Peonol; NSC 401442

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Han, Guanqun ;

Abstract: Mankind's sustainable development not only requires the capture and conversion of renewable energies but also necessitates the production of chemical goods from renewable carbon sources. Biomass is the only accessible and renewable carbon source. One major class of biomass is degradative small molecules, among which 5-hydroxymethylfurfural (HMF) is considered as a platform chemical and it can serve as a starting material to produce various upgrading compounds, eg, the oxidation products, 2, 5-furan dicarboxylic acid (FDCA), and 2, 5-diformylfuran (DFF), can act as biopolymer precursors. In this dissertation, we successfully demonstrated that ultrathin Ni/CdS nanosheets can be efficient photocatalyst to produce value-added bioproducts (eg, furoic acid, DFF, and FDCA) from biomass-derived molecules. Even more desirable is that the oxidative biomass upgrading can be integrated with H2 production.

Purchased from AmBeed: ; ; ; ; ; ;

Alternative Products

Product Details of Paeonol

CAS No. :552-41-0
Formula : C9H10O3
M.W : 166.17
SMILES Code : CC(C1=CC=C(OC)C=C1O)=O
Synonyms :
2'-Hydroxy-4'-methoxyacetophenone; Peonol; NSC 401442
MDL No. :MFCD00008730
InChI Key :UILPJVPSNHJFIK-UHFFFAOYSA-N
Pubchem ID :11092

Safety of Paeonol

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302+H312+H332-H315-H319-H335-H412
Precautionary Statements:P261-P273-P280-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • MAO-B

    MAO-B, IC50:42.5 μM

  • MAO-A

    MAO-A, IC50:54.6 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
HCT116 cells 7.8125, 15.625, 31.25, 62.5, 125, 250 and 500 µg/ml 12, 24, 48 and 72 hours To assess the inhibitory effect of Paeonol on HCT116 cell viability, the results showed that Paeonol significantly inhibited the proliferation of HCT116 cells in a dose- and time-dependent manner. Int J Mol Med. 2020 Aug;46(2):675-684.
SKOV3 cells 1.2 mM 24 and 48 hours To evaluate the inhibitory effect of Paeonol on cell proliferation, results showed that Paeonol significantly inhibited the proliferation of SKOV3 cells. Cell Death Dis. 2019 Aug 13;10(8):609.
A2780 cells 1.2 mM 24 and 48 hours To evaluate the inhibitory effect of Paeonol on cell proliferation, results showed that Paeonol significantly inhibited the proliferation of A2780 cells. Cell Death Dis. 2019 Aug 13;10(8):609.
NSC-34/hSOD1G93A (MT) 100 µM 24 hours Evaluate the protective effect of Paeonol against glutamate, LPS, and H2O2-induced cytotoxicity, results showed Paeonol significantly improved cell viability Antioxidants (Basel). 2022 Jul 18;11(7):1392.
NSC-34/hSOD1WT (WT) 100 µM 24 hours Evaluate the protective effect of Paeonol against glutamate, LPS, and H2O2-induced cytotoxicity, results showed Paeonol significantly improved cell viability Antioxidants (Basel). 2022 Jul 18;11(7):1392.
Cardiomyocytes 50 µM 24 hours Paeonol promotes Mfn2-mediated mitochondrial fusion, restores mitochondrial function and cell viability, and inhibits Dox-induced cardiomyocyte apoptosis and oxidative stress. J Adv Res. 2023 May;47:151-162.
Primary microglial cells 0.5 to 1 mM 24 hours Paeonol inhibited lipopolysaccharide-induced nitrite release and reduced the secretion of tumor necrosis factor-alpha and interleukin-1β. Neural Regen Res. 2013 Jun 25;8(18):1637-43.
RAW 264.7 cells 25, 50 µM 24 hours Evaluate the effect of paeonol on LPS-induced MAPK protein expression in RAW 264.7 cells. Results showed that paeonol significantly reduced the protein expression levels of COX-2 and NF-κB and affected the phosphorylation of p-p38. Biomolecules. 2022 Nov 3;12(11):1634.
RAW 264.7 cells 6.3, 12.5, 25, 50 µM 24 hours Evaluate the effect of paeonol on LPS-induced IL-6 and TNF-α production in RAW 264.7 cells. Results showed that paeonol inhibited the release of IL-6 and TNF-α in a concentration-dependent manner. Biomolecules. 2022 Nov 3;12(11):1634.
GMI-R1 cells 4 µM 24 hours Paeonol promotes the transformation of LPS-treated GMI-R1 microglia from the M1 phenotype to the M2 phenotype. CNS Neurosci Ther. 2023 Sep;29(9):2666-2679.
Human primary umbilical vein endothelial cell (HUVEC) 10 µM 24 hours To evaluate the effect of Paeonol on HUVEC cell viability, results showed that Paeonol treatment significantly enhanced HUVEC viability. Drug Des Devel Ther. 2023 May 24;17:1567-1582.
Aspergillus flavus 0.625 mg/mL 24 hours Paeonol significantly destroyed both the outer amorphous layer and the inner fibrous layer of A. flavus cell walls, leading to thinner cell walls and chaotic cytoplasm. Foods. 2021 Dec 1;10(12):2951.
Human umbilical vein/vascular endothelial cell line (HUVEC-C) 10 µM 24 hours, 48 hours, 72 hours To evaluate the effect of Paeonol on HUVEC-C cell numbers, results showed that Paeonol treatment significantly increased cell numbers. Drug Des Devel Ther. 2023 May 24;17:1567-1582.
RAW264.7 macrophages 32, 64, 128 µg/mL 3 hours pretreatment or 4 hours treatment To assess the anti-infection activity and mechanism of paeonol against P. aeruginosa infection in vitro, results showed paeonol downregulated the expression of QS-related virulence genes and reduced PAO1-induced cell damage Front Immunol. 2022 May 24;13:896874.
BV-2 microglial cells 10 or 30 µM 30 min pretreatment followed by 24 hours stimulation To investigate the effects of Paeonol on ATP-induced cell migratory activity. Results showed that Paeonol effectively reduced ATP-enhanced migratory activity. Int J Mol Sci. 2015 Apr 21;16(4):8844-60.
BV-2 microglial cells 3, 10, or 30 µM 30 min pretreatment followed by 24 hours stimulation To investigate the inhibitory effects of Paeonol on LPS/IFN-γ-induced inflammatory responses. Results showed that Paeonol significantly inhibited the release of NO and the expressions of iNOS and COX-2. Int J Mol Sci. 2015 Apr 21;16(4):8844-60.
Primary cardiomyocytes 25, 50, 100, 200 µM 48 hours To evaluate the effects of Paeonol on mitochondrial fusion and function in high glucose-treated cardiomyocytes. Results showed that 100 μmol/L Paeonol significantly increased mitochondrial volume, decreased mitochondrial number, inhibited mitochondrial oxidative stress, and improved ATP production and mitochondrial respiratory capacity. Redox Biol. 2021 Oct;46:102098.
SW1353 cells 3, 10, 30 µM 48 hours Evaluate the effect of Paeonol on the viability of SW1353 cells, showing no effect on cell viability at 3–30 μM Int J Mol Sci. 2014 Jul 2;15(7):11760-72.
JJ012 cells 3, 10, 30 µM 48 hours Evaluate the effect of Paeonol on the viability of JJ012 cells, showing no effect on cell viability at 3–30 μM Int J Mol Sci. 2014 Jul 2;15(7):11760-72.
NSC-34/hSOD1G93A (MT) 347 nM 5 min Evaluate the uptake characteristics of [3H]Paeonol, results showed time-, concentration-, and pH-dependent uptake Antioxidants (Basel). 2022 Jul 18;11(7):1392.
NSC-34/hSOD1WT (WT) 347 nM 5 min Evaluate the uptake characteristics of [3H]Paeonol, results showed time-, concentration-, and pH-dependent uptake Antioxidants (Basel). 2022 Jul 18;11(7):1392.
RAW 264.7 cells 6.3, 12.5, 25, 50 µM 6 hours Evaluate the effect of paeonol on LPS-induced mRNA expression of IL-6, IL-1β, and TNF-α in RAW 264.7 cells. Results showed that paeonol reduced the mRNA expression levels of these inflammatory cytokines in a concentration-dependent manner. Biomolecules. 2022 Nov 3;12(11):1634.
Organotypic hippocampal slice cultures 0.5 and 1 mM 72 hours Paeonol pretreatment markedly blocked lipopolysaccharide-induced hippocampal cell death and inhibited the release of nitrite and interleukin-1beta. Neural Regen Res. 2013 Jun 25;8(18):1637-43.
3T3-L1 cells 1000 µM 8 days Paeonol inhibits the differentiation of 3T3-L1 cells into mature adipocytes and reduces lipid accumulation. Nutrients. 2020 Jan 24;12(2):309.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
ICR mice LPS-induced neuroinflammation model Intraperitoneal injection 10 or 30 mg/kg Once daily for three consecutive days, followed by a single LPS injection To investigate the effects of Paeonol on LPS-induced motor coordination dysfunction and microglial activation. Results showed that Paeonol significantly improved motor coordination in LPS-injected mice and reduced microglial activation. Int J Mol Sci. 2015 Apr 21;16(4):8844-60.
Sprague-Dawley rats Chronic constrictive injury (CCI) model Intragastric administration 100 mg/kg Twice daily for 21 days Paeonol alleviates neuropathic pain by modulating microglial M1 and M2 polarization via the RhoA/p38MAPK signaling pathway. CNS Neurosci Ther. 2023 Sep;29(9):2666-2679.
Wistar rats Hepatic ischemia/reperfusion injury model Oral 100 mg/kg Once daily for 7 days To evaluate the protective effect of paeonol against hepatic ischemia/reperfusion injury, results showed that paeonol attenuated liver injury by inhibiting oxidative stress, inflammation, and apoptosis. Antioxidants (Basel). 2022 Aug 29;11(9):1687
Sprague-Dawley rats Dox-induced cardiotoxicity model Oral gavage 150 mg/kg Once daily for two weeks Paeonol activates the PKCε-Stat3-Mfn2 signaling pathway to promote mitochondrial fusion, alleviating Dox-induced cardiotoxicity and myocardial injury. J Adv Res. 2023 May;47:151-162.
BALB/c mice IMQ-induced psoriasis-like skin inflammation model Oral 20 mg/kg and 40 mg/kg Once daily for 7 days To evaluate the therapeutic effect of compound B12 on IMQ-induced psoriasis-like skin inflammation. Results showed that compound B12 significantly alleviated skin inflammation symptoms and PASI score. J Orthop Translat. 2024 Nov 24;50:1-13
BALB/c mice IMQ-induced psoriasis-like skin inflammation model Oral 20 mg/kg and 40 mg/kg Once daily for 7 days To evaluate the therapeutic effect of compound B12 on IMQ-induced psoriasis-like skin inflammation. Results showed that compound B12 significantly alleviated skin inflammation symptoms and PASI score. J Enzyme Inhib Med Chem. 2022 Dec;37(1):817-831
SPF mice PAO1 acute infection model Intragastric administration 25, 50, 100 mg/kg 3 consecutive days To evaluate the anti-infection activity of paeonol in vivo, results showed paeonol decreased the bacterial load in the lung and inhibited the mRNA expression of inflammation cytokines Front Immunol. 2022 May 24;13:896874.
BALB/c mice Lincomycin-induced antibiotic-associated diarrhea model Oral 25, 50, 100 mg/kg Twice daily for 7 days Evaluate the effect of paeonol on lincomycin-induced diarrhea in mice. Results showed that paeonol significantly improved diarrhea symptoms, reduced weight loss and water intake, and decreased serum levels of TNF-α and IL-4. Biomolecules. 2022 Nov 3;12(11):1634.
ApoE−/− mice Murine carotid artery catheter guide wires injury model Intraperitoneal injection 30 mg/kg Pretreated for 7 consecutive days, continued treatment after surgery until tissue collection To evaluate the effect of Paeonol on vascular stenosis after vascular injury, results showed that Paeonol treatment significantly suppressed vascular neointima formation. Drug Des Devel Ther. 2023 May 24;17:1567-1582.
BALB/c nude mice A2780 xenograft model Intraperitoneal injection 40 mg/kg Once every 2 days, total of 6 times (12 days) To evaluate the antitumor activity of Paeonol in vivo, results showed that Paeonol significantly inhibited tumor growth, and the effect was enhanced when combined with the autophagy inhibitor HCQ. Cell Death Dis. 2019 Aug 13;10(8):609.
Sprague-Dawley rats Diabetic cardiomyopathy model Oral gavage 75, 150, 300 mg/kg Once daily for 12 weeks To evaluate the protective effects of Paeonol on diabetic cardiomyopathy. Results showed that Paeonol (150 or 300 mg/kg/day) significantly improved cardiac function, reduced myocardial hypertrophy and fibrosis, inhibited cardiomyocyte apoptosis and oxidative stress, and promoted mitochondrial fusion and functional recovery. Redox Biol. 2021 Oct;46:102098.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

6.02mL

1.20mL

0.60mL

30.09mL

6.02mL

3.01mL

60.18mL

12.04mL

6.02mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

[1]Kong LD, Cheng CH, Tan RX. Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones. J Ethnopharmacol. 2004 Apr;91(2-3):351-5.

[2]Chou TC. Anti-inflammatory and analgesic effects of paeonol in carrageenan-evoked thermal hyperalgesia. Br J Pharmacol. 2003 Jul;139(6):1146-52.

[3]Lee H, Lee G, et al. Paeonol, a major compound of moutan cortex, attenuates Cisplatin-induced nephrotoxicity in mice. Evid Based Complement Alternat Med. 2013;2013:310989.

[4]Antidepressant-like Effect of Paeonol

[5]Tsai TH, Chou CJ, et al. Pharmacokinetics of paeonol after intravenous administration in rats. J Pharm Sci. 1994 Sep;83(9):1307-9.

[6]Ma L, Chuang CC, et al. Paeonol Protects Rat Heart by Improving Regional Blood Perfusion during No-Reflow. Front Physiol. 2016 Jul 21;7:298.

[7]Kong LD, Cheng CH, Tan RX. Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones. J Ethnopharmacol. 2004 Apr;91(2-3):351-5. doi: 10.1016/j.jep.2004.01.013. PMID: 15120460.

[8]Gao L, Wang Z, Lu D, Huang J, Liu J, Hong L. Paeonol induces cytoprotective autophagy via blocking the Akt/mTOR pathway in ovarian cancer cells. Cell Death Dis. 2019 Aug 13;10(8):609. doi: 10.1038/s41419-019-1849-x. PMID: 31406198; PMCID: PMC6690917.

[9]Wang Q, Xu X, Kang Z, Zhang Z, Li Y. Paeonol prevents IL-1β-induced inflammatory response and degradation of type II collagen in human primary chondrocytes. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2139-2145. doi: 10.1080/21691401.2019.1613418. PMID: 31146598.

 

Historical Records

Categories